Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

219,481-219,510 of 319,975

filter-aware
05
The slide highlights the two different delivery methods (IV vs Subcutaneous) for the same underlying treatment.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
06
The slide uses a hub-and-spoke visual arrangement around a central patient image.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
07
The slide uses a circular, iterative process diagram to represent the business strategy.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
08
The slide uses a central circular image overlaying four strategic pillars.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
09
The slide uses a 3D-like growth chart to illustrate simultaneous expansion strategies.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
10
The slide uses a chronological progression (Today vs Future) to outline product development strategy.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
11
The map uses teal dots for general approvals and a purple dot for a specific location (likely US/Canada focus).argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
12
The slide uses a pyramid structure to represent market size, with larger patient populations at the base.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
13
The slide uses a patient-centric approach to humanize clinical trial data and innovation progress.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Loop · Why Now1 hit
14
The slide outlines a clinical trial protocol timeline.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Loop · Why Now1 hit
15
The slide outlines a clinical trial protocol with a 1-3 week screening phase followed by a 30-week treatment period.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Loop · Why Now1 hit
16
The slide uses a split-screen layout to contrast the established MMN proof-of-concept (left) with the future clinical roadmap (right).argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
17
Includes a biological mechanism diagram on the left and a clinical trial design timeline on the right.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
18
The slide uses a hub-and-spoke style network visualization to represent partnerships.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
19
The slide uses a mix of checkmarks for completed items and specific timeframes for future items.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
20
The diagram uses a hub-and-spoke layout with the company logo at the center.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
21
The chart uses a horizontal bar format to represent clinical trial progress for multiple indications under three main programs (VYVGART, ARGX-117, ARGX-119).argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
22
Clinical trial design schematic showing randomization, screening criteria, and study endpoints.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
23
Clinical trial design diagram showing randomization, treatment arms (Efgartigimod vs Placebo), concomitant OCS usage, and interim analysis point.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
24
The slide outlines a multi-phase clinical trial structure with specific patient cohorts (IMNM, ASyS, DM) and a GO/NO-GO decision point.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
25
Clinical trial design diagram showing patient flow from screening through randomization to treatment and follow-up.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
01
Slide 1
argenx SE | Investor Presentation Deck | 7 slidesargenx SE | Investor Presentation Deck | 7 slides · argenx
Conference presentation Investor relations 1 hit
02
argenx SE | Investor Presentation Deck | 7 slidesargenx SE | Investor Presentation Deck | 7 slides · argenx
Conference presentation Investor relations 1 hit
03
The slide uses a clear contrast between the failed primary endpoint and the positive safety/PD profile to frame the conclusion.argenx SE | Investor Presentation Deck | 7 slides · argenx
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide uses a timeline-based clinical trial design framework.argenx SE | Investor Presentation Deck | 7 slides · argenx
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
05
The slide uses a mix of checkmark icons for completed items and text-based timelines for upcoming ones.argenx SE | Investor Presentation Deck | 7 slides · argenx
Conference presentation Investor relations Beat · Financials/MilestonesLoop · Cost Of Inaction1 hit
06
The slide uses a pyramid layout to represent market segments by patient population size.argenx SE | Investor Presentation Deck | 7 slides · argenx
Conference presentation Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
07
The slide uses a background image of an ocean with a digital network overlay, typical of corporate branding for biotech.argenx SE | Investor Presentation Deck | 7 slides · argenx
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
01
Slide 1
arm | Investor Presentation Deck | 8 slidesarm | Investor Presentation Deck | 8 slides · Arm
Conference presentation Investor relations 1 hit
02
The slide features a large central photo of the Arm leadership team at the Nasdaq podium, with smaller inset photos showing the crowd and office celebrations.arm | Investor Presentation Deck | 8 slides · Arm
Conference presentation Investor relations 1 hit